Last week, Inspire Investing presented our shareholder proposal regarding the company’s apparent coverage of gender transition interventions, including puberty blockers, cross-sex hormones, and surgeries for minors.
Rather than speaking only through statistics or policy arguments, we believed it was important for shareholders to hear directly from someone who has lived through these interventions firsthand. De-transitioner Chloe Cole addressed the annual meeting and shared her deeply personal experience.
Watch all of her powerful testimony below.
As Chloe stated in her remarks:
“Millions of American families trust Home Depot with their homes. It’s that legacy that makes it imperative to act now before the name ‘Home Depot’ is permanently attached to the sterilization and mutilation of children.”
She also warned that children cannot fully comprehend the lifelong consequences of irreversible medical decisions and emphasized that shareholders deserve transparency regarding whether company healthcare plans are subsidizing these interventions.
The legal, medical, and cultural landscape surrounding these procedures is changing rapidly. Increasing numbers of de-transitioners are speaking publicly, lawsuits are mounting, and medical authorities around the world are reevaluating standards of care for minors.
This proposal is ultimately about transparency, accountability, and long-term risk oversight.
How companies structure their healthcare plans has real-world consequences. It affects children, families, corporate reputation, and shareholder value.
Thank you to Chloe Cole for the courage to share your story publicly.
Tim Schwarzenberger, CFA is a Portfolio Manager and Director of Corporate Engagement for Inspire Investing. He previously served as Managing Director at Christian Brothers Investment Services (CBIS), where he was an integral member of the Investment Team responsible for implementing the firm’s strategy development, portfolio construction, and Catholic investing initiatives.
This content is for informational purposes only and not investment advice. Investing involves risk, including loss of principal. Inspire Investing may hold positions in companies discussed, creating potential conflicts of interest. Engagement efforts are not guaranteed to influence outcomes. Views expressed reflect Inspire’s values-based approach and may not align with all investors. Personal stories shared are individual experiences and not representative of others. Discussion includes sensitive subject matter and reflects personal viewpoints.
Last week, Inspire Investing presented our shareholder proposal regarding the company’s apparent coverage of gender transition interventions, including puberty blockers, cross-sex hormones, and surgeries for minors.
Rather than speaking only through statistics or policy arguments, we believed it was important for shareholders to hear directly from someone who has lived through these interventions firsthand. De-transitioner Chloe Cole addressed the annual meeting and shared her deeply personal experience.
Watch all of her powerful testimony below.
As Chloe stated in her remarks:
“Millions of American families trust Home Depot with their homes. It’s that legacy that makes it imperative to act now before the name ‘Home Depot’ is permanently attached to the sterilization and mutilation of children.”
She also warned that children cannot fully comprehend the lifelong consequences of irreversible medical decisions and emphasized that shareholders deserve transparency regarding whether company healthcare plans are subsidizing these interventions.
The legal, medical, and cultural landscape surrounding these procedures is changing rapidly. Increasing numbers of de-transitioners are speaking publicly, lawsuits are mounting, and medical authorities around the world are reevaluating standards of care for minors.
This proposal is ultimately about transparency, accountability, and long-term risk oversight.
How companies structure their healthcare plans has real-world consequences. It affects children, families, corporate reputation, and shareholder value.
Thank you to Chloe Cole for the courage to share your story publicly.
